-
Je něco špatně v tomto záznamu ?
Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine
A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV15-31604A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Freely Accessible Science Journals
od 2011-09-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
26740587
DOI
10.1098/rsob.150172
Knihovny.cz E-zdroje
- MeSH
- bromodeoxyuridin metabolismus MeSH
- buněčná smrt MeSH
- buněčné jádro metabolismus MeSH
- cytidindeaminasa metabolismus MeSH
- deoxycytidin analogy a deriváty metabolismus MeSH
- deoxyuridin analogy a deriváty metabolismus MeSH
- DNA metabolismus MeSH
- lidé MeSH
- malá interferující RNA metabolismus MeSH
- metabolom MeSH
- nádorové buněčné linie MeSH
- protilátky metabolismus MeSH
- replikace DNA MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000683
- 003
- CZ-PrNML
- 005
- 20201105083836.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1098/rsob.150172 $2 doi
- 024 7_
- $a 10.1098/rsob.150172 $2 doi
- 035 __
- $a (PubMed)26740587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ligasová, Anna $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic anna.ligasova@upol.cz.
- 245 10
- $a Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine / $c A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,
- 520 9_
- $a 5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.
- 650 _2
- $a protilátky $x metabolismus $7 D000906
- 650 _2
- $a bromodeoxyuridin $x metabolismus $7 D001973
- 650 _2
- $a buněčná smrt $7 D016923
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné jádro $x metabolismus $7 D002467
- 650 _2
- $a cytidindeaminasa $x metabolismus $7 D003564
- 650 _2
- $a DNA $x metabolismus $7 D004247
- 650 _2
- $a replikace DNA $7 D004261
- 650 _2
- $a deoxycytidin $x analogy a deriváty $x metabolismus $7 D003841
- 650 _2
- $a deoxyuridin $x analogy a deriváty $x metabolismus $7 D003857
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metabolom $7 D055442
- 650 _2
- $a malá interferující RNA $x metabolismus $7 D034741
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Liboska, Radek $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
- 700 1_
- $a Friedecký, David $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Mičová, Kateřina $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Adam, Tomáš, $d 1965- $7 xx0054162 $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Oždian, Tomáš $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Rosenberg, Ivan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
- 700 1_
- $a Koberna, Karel $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic karel.koberna@upol.cz.
- 773 0_
- $w MED00190574 $t Open biology $x 2046-2441 $g Roč. 6, č. 1 (2016), s. 150172
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26740587 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20201105083833 $b ABA008
- 999 __
- $a ok $b bmc $g 1179823 $s 961250
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 6 $c 1 $d 150172 $i 2046-2441 $m Open biology $n Open Biol $x MED00190574
- GRA __
- $a NV15-31604A $p MZ0
- LZP __
- $a Pubmed-20170103